Shunjun Fu

Targeting inflammasome/IL-1 pathways for cancer immunotherapy

Beichu Guo, Shunjun Fu, Jinyu Zhang et al. · Scientific Reports · 2016 · 302 citations · Full text

Life Sciences, Immunology, Oncology +17

Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer

Xuxu Sun, Sam C. Wang, Yonglong Wei et al. · Cancer Cell · 2017 · 255 citations

Medicine, Genetics, Oncology +16

A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI)

Fei Ji, Yao Liang, Shunjun Fu et al. · BMC Cancer · 2016 · 109 citations · Full text

Medicine, Oncology, Pathology +17

Preoperative Aspartate Aminotransferase to Platelet Ratio is an Independent Prognostic Factor for Hepatitis B-Induced Hepatocellular Carcinoma After Hepatic Resection

Shunli Shen, Shunjun Fu, Bin Chen et al. · Annals of Surgical Oncology · 2014 · 104 citations

Medicine, Hematology, Oncology +15

Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection

Shunjun Fu, Chao-Ying Qi, Weikai Xiao et al. · Surgery · 2013 · 85 citations

Medicine, Oncology, Pharmacology +16